Kronos Bio Inc. (KRON) Social Stream



Kronos Bio Inc. (KRON): $3.63

-0.28 (-7.16%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KRON to Watchlist
Sign Up

Industry: Biotech


Ranked

of 388

in industry

Kronos Bio Inc (KRON) Price Targets From Analysts

Use the tables below to see what analysts covering Kronos Bio Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $50 $36 $40.666 $7.45 445.85%
2021-12-06 4 $50 $36 $40.666 $7.45 445.85%
2021-12-22 4 $50 $25 $37 $7.45 396.64%
2022-02-24 4 $50 $22 $36 $7.45 383.22%
2022-03-08 4 $36 $22 $29.333 $7.45 293.73%

The Trend in the Analyst Price Target


Over the past 26 weeks, KRON's average price target has gone down $12.92.

Over the past 48 weeks, KRON's average upside potential has been 127.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-03 1 50 36 44.330 26.85 65.1%
2021-07-02 4 50 35 42.000 23.84 76.17%
2021-09-09 4 50 35 42.250 22.53 87.53%
2021-12-22 4 50 25 37.000 15.30 141.83%
2022-03-08 4 36 22 29.333 6.58 345.79%

KRON Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


KRON's average broker recommendation rating improved by 0 over the prior 90 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KRON as an investment opportunity.

  • In terms of how Kronos Bio Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 474.46% of that group.
  • In terms of how Kronos Bio Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 87.25% of that group.
  • In the context of stocks in the small market cap category, Kronos Bio Inc's average analyst price target is greater than 383.02% of them.
  • In the context of stocks in the small market cap category, Kronos Bio Inc's variance in analysts' estimates is lower than -231.91% of them.

In the Pharmaceutical Products industry, KPTI, KNTE, and KNSA are the three stocks most similar to Kronos Bio Inc regarding the price target and analyst recommendation information presented here.

Is KRON a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8944 seconds.